Clinical Trials Directory

Trials / Completed

CompletedNCT01161017

Mechanism-based Choice of Therapy for Pain: Can Successful Prevention of Migraine be Coupled to a Psychophysical Pain Modulation Profile?

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
67 (actual)
Sponsor
Rambam Health Care Campus · Academic / Other
Sex
All
Age
18 Years – 75 Years
Healthy volunteers
Not accepted

Summary

Mechanism-based choice of therapy for pain: Can successful prevention of migraine be coupled to a psychophysical pain modulation profile?

Conditions

Interventions

TypeNameDescription
DRUGAmitriptylineInitial dose of 12.5mg will be given for 2 days. Then, daily 25mg will be taken for additional 8 weeks
DRUGTopiramateFor the first 5 days of treatment 25mg is prescribed and should be ingested in one evening dose. For another 5 days, 25g dose should be taken twice a day (morning and evening). For the next 5 days, morning dose will be 25mg; evening dose will be 50mg. For the remaining 6 weeks of treatment, a dose of 50mg twice a day will be advised

Timeline

Start date
2008-07-01
Primary completion
2014-05-01
Completion
2014-05-01
First posted
2010-07-13
Last updated
2017-10-11

Locations

1 site across 1 country: Israel

Source: ClinicalTrials.gov record NCT01161017. Inclusion in this directory is not an endorsement.